SROWK

This brand name is authorized in Nigeria.

Active ingredients

The drug SROWK contains one active pharmaceutical ingredient (API):

1	Potassium chloride UNII 660YQ98I10 - POTASSIUM CHLORIDE
	Potassium plays a vital physiological role in maintenance of normal electrical excitability of nerve and muscle. It is also important in the genesis and correction of imbalances of acid-base metabolism.
	Read more about Potassium chloride

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-101103	Prolonged-release tablet	Srowk Tablets Prolonged Release Potassium Chloride TAB_DR 600 mg 4 x 10's (in Alu-PVC blisters)	Film Coated Tablet Pink colored, round shaped, biconvex, film coated tablets, prolonged release tablet, plain on both sides	22/11/2024

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A12BA01	Potassium chloride	A Alimentary tract and metabolism → A12 Mineral supplements → A12B Potassium → A12BA Potassium
Discover more medicines within A12BA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-101103